Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.

[1]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[2]  J. Dallongeville,et al.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.

[3]  E. Quinet,et al.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. , 1980, The Journal of clinical investigation.

[4]  A. Evans,et al.  A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  G. Utermann,et al.  Apolipoprotein E phenotyping from serum by Western blotting , 1986 .

[6]  R. Mahley,et al.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. , 1978, Biochemistry.

[7]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[8]  K. Weisgraber.  Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.

[9]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[10]  W. Brown,et al.  Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. , 1983, Journal of lipid research.

[11]  H. Kaffarnik,et al.  Differential Distribution of Apolipoprotein E Isoforms in Human Plasma Lipoproteins , 1989, Arteriosclerosis.

[12]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[13]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[14]  R. Gregg,et al.  Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. , 1981, Science.

[15]  M. Tremblay,et al.  Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[17]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[18]  K. Weisgraber,et al.  Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. , 1991, The Journal of biological chemistry.

[19]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  A. von Eckardstein,et al.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Arveiler,et al.  Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde. , 1996, Journal of lipid research.

[22]  J. Fruchart,et al.  Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E. , 1988, Journal of immunoassay.

[23]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[24]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[25]  R. Mahley,et al.  Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. , 1978, The Journal of biological chemistry.

[26]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[27]  D. Agard,et al.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .

[28]  R. Mahley,et al.  Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. , 1982, The Journal of biological chemistry.

[29]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .